4.8 Article

MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits

Journal

NATURE CELL BIOLOGY
Volume 14, Issue 6, Pages 567-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ncb2491

Keywords

-

Categories

Funding

  1. George Williams Hooper Foundation
  2. NIH [P50 CA091956]
  3. DoD [PC094054, W81XWH0810736]
  4. NCI [CA122086]
  5. Susan B. Komen foundation [FA50703855]
  6. Mayo Clinic Breast Cancer SPORE [CA116201]
  7. NIH/NCI [R37CA064786, U01CA143233, U54CA143836, U54CA126552]
  8. Department of Energy OBER [DE-AC02-05CH1123]
  9. U.S. Department of Defense (DOD) [W81XWH0810736] Funding Source: U.S. Department of Defense (DOD)

Ask authors/readers for more resources

Overexpression of MYC transforms cells in culture, elicits malignant tumours in experimental animals and is found in many human tumours. We now report the paradoxical finding that this powerful oncogene can also act as a suppressor of cell motility, invasiveness and metastasis. Overexpression of MYC stimulated proliferation of breast cancer cells both in culture and in vivo as expected, but inhibited motility and invasiveness in culture, and lung and liver metastases in xenografted tumours. We show further that MYC represses transcription of both subunits of alpha(v),beta(3) integrin, and that exogenous expression of beta(3) integrin in human breast cancer cells that do not express this integrin rescues invasiveness and migration when MYC is downregulated. These data uncover an unexpected function of MYC, provide an explanation for the hitherto puzzling literature on the relationship between MYC and metastasis, and reveal a variable that could influence the development of therapies that target MYC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available